MinichMacGregor Wealth Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-285
Closed -$3.92K 128
2022
Q4
$3.92K Buy
+285
New +$3.96K ﹤0.01% 506
2018
Q4
Sell
-285
Closed -$6K 114
2018
Q3
$6K Hold
285
﹤0.01% 366
2018
Q2
$6K Hold
285
﹤0.01% 359
2018
Q1
$4K Hold
285
﹤0.01% 382
2017
Q4
$4K Hold
285
﹤0.01% 378
2017
Q3
$4K Hold
285
﹤0.01% 358
2017
Q2
$4K Hold
285
﹤0.01% 354
2017
Q1
$4K Hold
285
﹤0.01% 350
2016
Q4
$4K Hold
285
﹤0.01% 347
2016
Q3
$4K Hold
285
﹤0.01% 342
2016
Q2
$4K Hold
285
﹤0.01% 334
2016
Q1
$3K Hold
285
﹤0.01% 335
2015
Q4
$4K Buy
+285
New +$3.51K ﹤0.01% 293

Other funds holding ANGO

MinichMacGregor Wealth Management's ANGO Position: Q1 2023 in Review

MinichMacGregor Wealth Management sold out of AngioDynamics (ANGO) in Q1 2023, closing a stake of 285 shares — an estimated $3.92K sold.

MinichMacGregor Wealth Management first reported a position in ANGO in Q4 2015 and held it in 13 quarters. The position peaked at $6K in Q3 2018. 153 funds tracked by Wall St. Rank hold ANGO as of Q1 2023.

  • MinichMacGregor Wealth Management reported no remaining AngioDynamics position as of Q1 2023 after selling out during the quarter.
  • MinichMacGregor Wealth Management sold 285 AngioDynamics shares in Q1 2023, an estimated $3.92K.
  • MinichMacGregor Wealth Management first reported a position in AngioDynamics in Q4 2015 and held it in 13 quarters.
  • MinichMacGregor Wealth Management's AngioDynamics position peaked at $6K in Q3 2018.
  • 153 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2023.

Based on MinichMacGregor Wealth Management's 13F filing for Q1 2023, filed 19 Apr 2023.